Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 10—October 2018

Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA

Richard S. GarfeinComments to Author , Lin Liu, Jazmine Cuevas-Mota, Kelly Collins, Fatima Muñoz, Donald G. Catanzaro, Kathleen Moser, Julie Higashi, Teeb Al-Samarrai, Paula Kriner, Julie Vaishampayan, Javier Cepeda, Michelle A. Bulterys, Natasha K. Martin, Phillip Rios, and Fredric Raab
Author affiliations: University of California San Diego, La Jolla, California, USA (R.S. Garfein, L. Liu, J. Cuevas-Mota, K. Collins, F. Muñoz, J. Cepeda, M.A. Bulterys, N.K. Martin, P. Rios, F. Raab); University of Arkansas, Fayetteville, Arkansas, USA (D.G. Catanzaro); San Diego County Health and Human Services Agency, San Diego, California, USA (K. Moser); San Francisco Department of Public Health, San Francisco, California, USA (J. Higashi); Santa Clara County Public Health Department, San Jose, California, USA (T. Al-Samarrai); Imperial County Public Health Department, El Centro, California, USA (P. Kriner); San Joaquin Public Health Services, Stockton, California, USA (J. Vaishampayan)

Main Article

Table 4

Multivariable linear regression analysis of factors associated with FEDO among patients treated for tuberculosis, 5 California health districts, 2015–2016*

Beta coefficient
p value
Months on VDOT (per month)
Country of birth (referent: other)
Mexico −0.095 0.022 <0.001
United States
Perceived ease or difficulty of VDOT (referent: very easy)
Somewhat easy −0.003 0.024 0.90
Somewhat or very difficult
Took medications while away from home (referent: never or rarely)
Less than half or half the time −0.004 0.020 0.83
Most of the time or always
Had problems using the VDOT application (referent: never)
Rarely −0.001 0.018 0.97
Less than half the time −0.040 0.029 0.16
More than half the time −0.220 0.041 <0.001

*FEDO, fraction of expected doses observed = number of complete doses observed through VDOT divided by the number of doses expected; VDOT, video directly observed therapy.

Main Article

Page created: September 16, 2018
Page updated: September 16, 2018
Page reviewed: September 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.